Literature DB >> 4606232

Antihypertensive effects of practolol and sotalol.

H Sundquist, M Anttila, M Arstila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4606232     DOI： 10.1002/cpt1974163part1465

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  16 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Combination of clonidine and sotalol in hypertension.

Authors:  H Saarimaa
Journal:  Br Med J       Date:  1976-04-03

Review 3.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

4.  Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication.

Authors:  P J Neuvonen; E Elonen; T Vuorenmaa; M Laakso
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 5.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

6.  Fixed combination of sotalol and hydrochlorothiazide in the treatment of uncomplicated hypertension.

Authors:  A Jäättelä
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

8.  Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors:  T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

9.  The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

Authors:  T B Tjandramaga; R Verbeeck; J Thomas; R Verbesselt; R Verberckmoes; P J Schepper
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  Comparison of once and twice daily administration of sotalol in the treatment of hypertension.

Authors:  I Parvinen; E Paukkala
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.